Skip to main content
. 2021 Apr 20;12:636752. doi: 10.3389/fphar.2021.636752

TABLE 3.

Baseline characteristics of participants.

Measurements (Unit) Banha-Sasim-Tang (n = 15) Placebo (n = 16) p-value
Age (yr) 47.07 ± 12.24 50.0 6 ± 10.82 0.61 a
Male/Female 4/11 7/9 0.34 b
Body weight (kg) 57.99 ± 10.67 62.36 ± 13.04 0.27 a
Height (cm) 162.16 ± 7.48 163.53 ± 10.35 0.26 a
BMI (kg/m2) 21.97 ± 3.13 22.84 ± 2.44 0.34 a
NDI-K 79.60 ± 30.27 68.25 ± 27.32 0.52 a
VAS (cm) 7.57 ± 1.03 6.64 ± 1.63 0.09 a
Total ghrelin (pmol/L) 620.61 ± 429.04 515.37 ± 488.65 0.53 a
Acyl-ghrelin (pmol/L) 166.09 ± 198.34 235.89 ± 326.30 0.48 a
Des-acyl-ghrelin (pmol/L) 454.54 ± 348.43 279.48 ± 292.73 0.14 a

BMI; body mass index. Scores are marked in (means ± SD).

a

Independent t-test

b

Pearson’s chi-square test